44 related articles for article (PubMed ID: 12236624)
1. A positron emission tomography occupancy study of brexpiprazole at dopamine D
Girgis RR; Forbes A; Abi-Dargham A; Slifstein M
Neuropsychopharmacology; 2020 Apr; 45(5):786-792. PubMed ID: 31847007
[TBL] [Abstract][Full Text] [Related]
2. Effect of Sarizotan, a 5-HT1a and D2-like receptor agonist, on respiration in three mouse models of Rett syndrome.
Abdala AP; Lioy DT; Garg SK; Knopp SJ; Paton JF; Bissonnette JM
Am J Respir Cell Mol Biol; 2014 Jun; 50(6):1031-9. PubMed ID: 24351104
[TBL] [Abstract][Full Text] [Related]
3. The selective 5-HT
Fisher R; Hikima A; Morris R; Jackson MJ; Rose S; Varney MA; Depoortere R; Newman-Tancredi A
Neuropharmacology; 2020 May; 167():107997. PubMed ID: 32057799
[TBL] [Abstract][Full Text] [Related]
4. Effects of sarizotan in animal models of ADHD: challenging pharmacokinetic-pharmacodynamic relationships.
Danysz W; Flik G; McCreary A; Tober C; Dimpfel W; Bizot JC; Kostrzewa R; Brown RW; Jatzke CC; Greco S; Jenssen AK; Parsons CG
J Neural Transm (Vienna); 2015 Sep; 122(9):1221-38. PubMed ID: 25796190
[TBL] [Abstract][Full Text] [Related]
5. Intramolecular carbolithiation of N-allyl-ynamides: an efficient entry to 1,4-dihydropyridines and pyridines - application to a formal synthesis of sarizotan.
Gati W; Rammah MM; Rammah MB; Evano G
Beilstein J Org Chem; 2012; 8():2214-22. PubMed ID: 23365632
[TBL] [Abstract][Full Text] [Related]
6. SERT and NET occupancy by venlafaxine and milnacipran in nonhuman primates: a PET study.
Takano A; Halldin C; Farde L
Psychopharmacology (Berl); 2013 Mar; 226(1):147-53. PubMed ID: 23090625
[TBL] [Abstract][Full Text] [Related]
7. SEP-225289 serotonin and dopamine transporter occupancy: a PET study.
DeLorenzo C; Lichenstein S; Schaefer K; Dunn J; Marshall R; Organisak L; Kharidia J; Robertson B; Mann JJ; Parsey RV
J Nucl Med; 2011 Jul; 52(7):1150-5. PubMed ID: 21680689
[TBL] [Abstract][Full Text] [Related]
8. Local administration of sarizotan into the subthalamic nucleus attenuates levodopa-induced dyskinesias in 6-OHDA-lesioned rats.
Marin C; Aguilar E; Rodríguez-Oroz MC; Bartoszyk GD; Obeso JA
Psychopharmacology (Berl); 2009 Jun; 204(2):241-50. PubMed ID: 19159919
[TBL] [Abstract][Full Text] [Related]
9. Putative antipsychotics with pronounced agonism at serotonin 5-HT1A and partial agonist activity at dopamine D2 receptors disrupt basal PPI of the startle reflex in rats.
Auclair AL; Galinier A; Besnard J; Newman-Tancredi A; Depoortère R
Psychopharmacology (Berl); 2007 Jul; 193(1):45-54. PubMed ID: 17393144
[TBL] [Abstract][Full Text] [Related]
10. F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. II. Activity in models of positive symptoms of schizophrenia.
Depoortère R; Bardin L; Auclair AL; Kleven MS; Prinssen E; Colpaert F; Vacher B; Newman-Tancredi A
Br J Pharmacol; 2007 May; 151(2):253-65. PubMed ID: 17375086
[TBL] [Abstract][Full Text] [Related]
11. F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. III. Activity in models of cognition and negative symptoms.
Depoortère R; Auclair AL; Bardin L; Bruins Slot L; Kleven MS; Colpaert F; Vacher B; Newman-Tancredi A
Br J Pharmacol; 2007 May; 151(2):266-77. PubMed ID: 17375085
[TBL] [Abstract][Full Text] [Related]
12. A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy.
Kapur S; Zipursky R; Jones C; Shammi CS; Remington G; Seeman P
Arch Gen Psychiatry; 2000 Jun; 57(6):553-9. PubMed ID: 10839333
[TBL] [Abstract][Full Text] [Related]
13. The effect of a 5-HT1A receptor agonist on striatal dopamine release.
Bantick RA; De Vries MH; Grasby PM
Synapse; 2005 Aug; 57(2):67-75. PubMed ID: 15906386
[TBL] [Abstract][Full Text] [Related]
14. Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors.
Seeman P; Tallerico T
Mol Psychiatry; 1998 Mar; 3(2):123-34. PubMed ID: 9577836
[TBL] [Abstract][Full Text] [Related]
15. A new framework for investigating antipsychotic action in humans: lessons from PET imaging.
Kapur S
Mol Psychiatry; 1998 Mar; 3(2):135-40. PubMed ID: 9577837
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of EMD 128 130 occupancy of the 5-HT1A and the D2 receptor: a human PET study with [11C]WAY-100635 and [11C]raclopride.
Rabiner EA; Gunn RN; Wilkins MR; Sedman E; Grasby PM
J Psychopharmacol; 2002 Sep; 16(3):195-9. PubMed ID: 12236624
[TBL] [Abstract][Full Text] [Related]
17. Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride.
Yokoi F; Gründer G; Biziere K; Stephane M; Dogan AS; Dannals RF; Ravert H; Suri A; Bramer S; Wong DF
Neuropsychopharmacology; 2002 Aug; 27(2):248-59. PubMed ID: 12093598
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
